ESC 365 - Impact of chronic kidney disease on mid-term prognosis of stable angina patients with high-dose or low-dose pitavastatin treatment: REAL-CAD sub-study

ESC Premium Access

Impact of chronic kidney disease on mid-term prognosis of stable angina patients with high-dose or low-dose pitavastatin treatment: REAL-CAD sub-study

Session: Genetic Predisposition and Management of Dyslipidemia

Topic: Drug therapy

Speaker: Doctor M. Abe (Kyoto, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Mitsuru Abe

Kyoto Medical Centre, Kyoto (Japan)

0 follower

2 more presentations in this session

Risk factors for the presence and development of Familial Dysbetalipoproteinemia in subjects from the general population with an APOE2E2 genotype

Speaker: Ms B. Heidemann (Utrecht, NL)

Optimal blood lipid levels counterbalance high polygenic risk of coronary artery disease in 130 000 individuals

Speaker: Doctor G. Botta (Rome, IT)

Access the full session

Genetic Predisposition and Management of Dyslipidemia

Speakers: Doctor M. Abe, Ms B. Heidemann, Doctor G. Botta

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources